09:25
2026-07-01
fortune.com
generative-ai
Eli Lilly just placed a $40 million bet on the next injectable boom
Eli Lilly invested $40 million in Absci, a generative AI drug company, to develop ABS-201, an injectable antibody for baldness and endometriosis. The deal, part of a $100 million stock offering, aims …